|Scheme||Details||Typical timelines and budget|
|AZ Open Innovation||Access AZ screening library against target of interest.||Work carried out by AstraZeneca|
|BHF Translational Award||Supports the pre-clinical development of new cardiovascular medicines and technologies so that they are attractive for follow-on funding: bridging the funding gap between promising innovations and the clinic||£250k|
|CRUK Small Molecule Drug Discovery Project Awards||Identify and characterise small molecule novel therapeutic targets and to identify and develop novel therapeutic entities for the benefit of cancer patients. New target identification & validation.||One to three years, £300k|
|Eli Lilly Open Innovation Drug Discovery Scheme||R & D Challenges: access screening libraries, in sillico design and synthesis.||As required to progress project|
|European Lead Factory||Access 300k (to 500k) ‘lead-like’ compounds to screen against a novel target. Generates qualified hit list of up to 50 compounds.
Must be in 384 format or demonstrate feasibility to be converted to 384.
|Work carried out by European Lead Factory|
|GSK Discovery Fast Track||Screening service against target of interest.
Not always open.
|As required to progress project|
|GSK Discovery Partnership with Academia||Integrated GSK-academic partnerships that can translate innovative research||Six -12 months|
|Innovate UK||Multiple schemes which are updated regularly, ranging from small innovation vouchers to large, collaborative programmes. Usually industry-led.||Various|
|MRC Biomedical catalyst||Early stage, small molecule, drug discovery. Will fund development of therapeutics.||Up to three years, £3M|
|Wellcome Trust Seed award||Small, one-off grants to help researchers develop original and innovative ideas to a position where they would be able to be competitive for a larger award from the Wellcome Trust, or another source.||Up to two years, £100k|